{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:07Z","timestamp":1792782907157,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:00:00Z","timestamp":1575072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,30]],"date-time":"2019-11-30T00:00:00Z","timestamp":1575072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grant from Science Technology Department of Zhejiang province, China","award":["2017C33206"],"award-info":[{"award-number":["2017C33206"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10096-019-03768-9","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T06:58:00Z","timestamp":1575269880000},"page":"607-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical application of QuantiFERON-TB Gold in-tube in the diagnosis and treatment of tuberculosis"],"prefix":"10.1007","volume":"39","author":[{"given":"Guangming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9090-7380","authenticated-orcid":false,"given":"Huabin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,30]]},"reference":[{"key":"3768_CR1","first-page":"15","volume-title":"Global tuberculosis report 2016[R]","author":"World Health Organization","year":"2016","unstructured":"World Health Organization (2016) Global tuberculosis report 2016[R]. WHO, Geneva, pp 15\u201342"},{"issue":"1","key":"3768_CR2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12879-018-3344-x","volume":"18","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Kang JY, Sl K et al (2018) Predictors for false-negative QuantiFERON-TB Gold assay results in patients with extrapulmonary tuberculosis[J]. BMC Infect Dis 18(1):457","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3768_CR3","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1542\/peds.2010-1725","volume":"127","author":"AT Cruz","year":"2011","unstructured":"Cruz AT, Geltemeyer AM, Starke JR et al (2011) Comparing the tuberculin skin test and T-SPOT.TB blood test in children[J]. Pediatrics 127(1):e31\u2013e38","journal-title":"Pediatrics"},{"issue":"8","key":"3768_CR4","doi-asserted-by":"publisher","first-page":"e12287","DOI":"10.1371\/journal.pone.0012287","volume":"5","author":"S Burl","year":"2010","unstructured":"Burl S, Adetifa UJ, Cox M et al (2010) The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life[J]. PloS one 5(8):e12287","journal-title":"PloS one"},{"issue":"7","key":"3768_CR5","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1093\/cid\/ciu022","volume":"58","author":"H Sohn","year":"2014","unstructured":"Sohn H, Aero AD, Menzies D et al (2014) Xpert MTB\/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact[J]. Clin Infect Dis 58(7):970\u2013976","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3768_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jinf.2013.11.012","volume":"68","author":"E Bunsow","year":"2014","unstructured":"Bunsow E, Ruiz-Serrano MJ, Lopez Roa P et al (2014) Evaluation of GeneXpert MTB\/RIF for the detection of Mycobacterium tuberculosis and resistance to rifampin in clinical specimens[J]. J Infect 68(4):338\u2013343","journal-title":"J Infect"},{"issue":"1","key":"3768_CR7","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3969\/j.issn.1671-0800.2016.01.016","volume":"28","author":"JY Wang","year":"2016","unstructured":"Wang JY, Zhou DZ, Xu YL (2016) Clinical application of release enzyme immunoassay in vitro for mycobacterium tuberculosis[J]. Modem Pract Med 28(1):32\u201333. https:\/\/doi.org\/10.3969\/j.issn.1671-0800.2016.01.016","journal-title":"Modem Pract Med"},{"issue":"3","key":"3768_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update[J]. Ann Intern Med 149(3):177\u2013184","journal-title":"Ann Intern Med"},{"issue":"5","key":"3768_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1378\/chest.07-1995","volume":"133","author":"Y Kobashi","year":"2008","unstructured":"Kobashi Y, Mouri K, Yagi S et al (2008) Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis[J]. Chest 133(5):1196\u20131202","journal-title":"Chest"},{"issue":"1","key":"3768_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1183\/09031936.00114810","volume":"37","author":"M Sester","year":"2011","unstructured":"Sester M, Sotgiu G, Lange C et al (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis[J]. Eur Respir J 37(1):100\u2013111","journal-title":"Eur Respir J"},{"issue":"8","key":"3768_CR11","doi-asserted-by":"publisher","first-page":"e0103763","DOI":"10.1371\/journal.pone.0136257","volume":"10","author":"B Lei","year":"2015","unstructured":"Lei B, Tao L, Ni D et al (2015) Fluctuating behavior and influential factors in the performance of the QuantiFERON-TB Gold in-tube assay in the diagnosis of tuberculosis[J]. PLoS One 10(8):e0103763","journal-title":"PLoS One"},{"issue":"1","key":"3768_CR12","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1038\/s41598-018-24285-3","volume":"8","author":"F Du","year":"2018","unstructured":"Du F, Xie L, Zhang Y et al (2018) Prospective comparison of QFT-GIT and T-SPOT.TB assays for diagnosis of active tuberculosis[J]. Sci Rep 8(1):5882","journal-title":"Sci Rep"},{"issue":"56","key":"3768_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22560","volume":"22","author":"I Abubakar","year":"2018","unstructured":"Abubakar I, Lalvan A, Southern J et al (2018) Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study[J]. Health Technol Assess 22(56):1\u201396","journal-title":"Health Technol Assess"},{"issue":"1","key":"3768_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1186\/s12879-016-1901-8","volume":"16","author":"AE Nijhawan","year":"2016","unstructured":"Nijhawan AE, Iroh PA, Brown LS et al (2016) Cost analysis of tuberculin skin test and the QuantiFERON-TB Gold in-tube test for tuberculosis screening in a correctional setting in Dallas, Texas, USA[J]. BMC Infect Dis 16(1):564","journal-title":"BMC Infect Dis"},{"issue":"3","key":"3768_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/labmed\/lmx022","volume":"48","author":"Y Jeon","year":"2017","unstructured":"Jeon Y, Kim MJ, Lee WI (2017) Diagnostic utility of new equation for active tuberculosis based on parameters of interferon-\u03b3 release assay[J]. Lab Med 48(3):214\u2013219","journal-title":"Lab Med"},{"issue":"9","key":"3768_CR16","doi-asserted-by":"publisher","first-page":"e0161983","DOI":"10.1371\/journal.pone.0161983","volume":"11","author":"E Ayubi","year":"2016","unstructured":"Ayubi E, Doosti-Irani A, Sanjari MA et al (2016) The clinical usefulness of tuberculin skin test versus interferon-gamma release assays for diagnosis of latent tuberculosis in HIV patients: A Meta-Analysis[J]. PLoS One 11(9):e0161983","journal-title":"PLoS One"},{"issue":"1","key":"3768_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12879-016-1875-6","volume":"16","author":"H Esmail","year":"2016","unstructured":"Esmail H, Thienemann F, Oni T et al (2016) QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response[J]. BMC Infect Dis 16(1):545","journal-title":"BMC Infect Dis"},{"key":"3768_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.tube.2015.10.005","volume":"96","author":"M Prabhavathi","year":"2016","unstructured":"Prabhavathi M, Ahamed Kabeer BS, Deenadayalan A et al (2016) In vitro QuantiFERON-TB gold antigen specific interleukin-1beta to diagnose TB among HIV-positive subjects[J]. Tuberculosis (Edinb) 96:27\u201330","journal-title":"Tuberculosis (Edinb)"},{"issue":"10","key":"3768_CR19","doi-asserted-by":"publisher","first-page":"e107245","DOI":"10.1371\/journal.pone.0107245","volume":"9","author":"C Danel","year":"2014","unstructured":"Danel C, Kabran M, Inwoley A et al (2014) Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in C\u00f4te d'Ivoire, West Africa[J]. PLoS One 9(10):e107245","journal-title":"PLoS One"},{"issue":"3","key":"3768_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/ijerph14030236","volume":"14","author":"Ping-Chin Chang","year":"2017","unstructured":"Chang PC, Wang PH, Chen KT (2017) Use of the QuantiFERON-TB Gold in-tube test in the diagnosis and monitoring of treatment efficacy in active pulmonary tuberculosis[J]. Int J Environ Res Public Health:14(3)","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"10","key":"3768_CR21","first-page":"1146","volume":"12","author":"SK Katiyar","year":"2008","unstructured":"Katiyar SK, Sampath A, Bihari S et al (2008) Use of the QuantiFERON-TB Gold in-tube test to monitor treatment efficacy in active pulmonary tuberculosis[J]. Int J Tuberc Lung Dis 12(10):1146\u20131152","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"3768_CR22","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1378\/chest.13-1232","volume":"145","author":"JL Johnson","year":"2014","unstructured":"Johnson JL, Geldenhuys H, Thiel BA et al (2014) Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB Gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence Area[J]. Chest 145(3):612\u2013617","journal-title":"Chest"},{"issue":"4","key":"3768_CR23","first-page":"503","volume":"89","author":"J Seto","year":"2014","unstructured":"Seto J, Ahiko T (2014) Effectiveness of interferon-gamma release assays in the tuberculosis contact investigation of elderly people[J]. Kekkaku 89(4):503\u2013508","journal-title":"Kekkaku"},{"issue":"11","key":"3768_CR24","doi-asserted-by":"publisher","first-page":"873","DOI":"10.13602\/j.cnki.jcls.2014.11.20","volume":"32","author":"ZH Chen","year":"2014","unstructured":"Chen ZH, Yu YY, Dai SB, Zhang XP, Wan XJ, Tan YH (2014) Analysis of uncertain results of whole blood gamma-interferon release test QFT-GIT[J]. Chin J Clin Lab Sci 32(11):873\u2013875. https:\/\/doi.org\/10.13602\/j.cnki.jcls.2014.11.20","journal-title":"Chin J Clin Lab Sci"},{"issue":"1","key":"3768_CR25","first-page":"12","volume":"8","author":"WP Mo","year":"2019","unstructured":"Mo WP, Zhong YC, Chen ZL, Zhang YY (2019) Analysis of causes of uncertainty in QFT results of gamma-interferon release test[J]. Clin Lab J (Electron Ed) 8(1):12\u201313","journal-title":"Clin Lab J (Electron Ed)"},{"issue":"6","key":"3768_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.5588\/ijtld.16.0764","volume":"21","author":"L Telisinghe","year":"2017","unstructured":"Telisinghe L, Amofa-Sekyi M, Maluzi K et al (2017) The sensitivity of the QuantiFERON\u00ae-TB Gold Plus assay in Zambian adults with active tuberculosis[J]. Int J Tuberc Lung Dis 21(6):690\u2013696","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"3768_CR27","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/cid\/ciu045","volume":"58","author":"CH Kim","year":"2014","unstructured":"Kim CH, Lim JK, Yoo SS et al (2014) Diagnostic performance of the QuantiFERON-TB Gold in-tube assay and factors associated with nonpositive results in patients with miliary tuberculosis[J]. Clin Infect Dis 58(7):986\u2013989","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3768_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.5588\/ijtld.13.0813","volume":"18","author":"MC Aichelburg","year":"2014","unstructured":"Aichelburg MC, Mandorfer M, Tittes J et al (2014) The association of smoking with IGRA and TST results in HIV-1-infected subjects[J]. Int J Tuberc Lung Dis 18(6):709\u2013716","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"3768_CR29","doi-asserted-by":"publisher","first-page":"582","DOI":"10.5588\/ijtld.14.0553","volume":"19","author":"JC Choi","year":"2015","unstructured":"Choi JC, Jarlsberg LG, Grinsdale JA et al (2015) Reduced sensitivity of the QuantiFERON(\u00ae) test in diabetic patients with smear-negative tuberculosis[J]. Int J Tuberc Lung Dis 19(5):582\u2013588","journal-title":"Int J Tuberc Lung Dis"},{"issue":"25","key":"3768_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.19347\/j.cnki.2096-1413.201825047","volume":"3","author":"H Wang","year":"2018","unstructured":"Wang H, Zhen SP, Gao T (2018) Application of tuberculosis interferon gamma release assay (TB-IGRA) in the diagnosis of tuberculosis[J]. Clin Res Pract 3(25):97\u201398. https:\/\/doi.org\/10.19347\/j.cnki.2096-1413.201825047","journal-title":"Clin Res Pract"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03768-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-019-03768-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-019-03768-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T19:20:01Z","timestamp":1606591201000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-019-03768-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,30]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["3768"],"URL":"https:\/\/doi.org\/10.1007\/s10096-019-03768-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,30]]},"assertion":[{"value":"3 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}